銳珂醫(yī)療公司

????2007年，柯達(dá)決定以近25億美元的低價出售其醫(yī)療集團(tuán)公司?，F(xiàn)在該集團(tuán)更名為銳珂醫(yī)療（CareStream Health），是加拿大最大的公司之一奧奈克斯公司（Onex Corporation）的子公司。銳珂專攻的領(lǐng)域有數(shù)字放射顯影，醫(yī)療與牙科成像，醫(yī)療IT和分子成像。當(dāng)時這一出售招致了批評，因?yàn)樵谟行┤丝磥?，醫(yī)療成像技術(shù)是比消費(fèi)成像更穩(wěn)定的業(yè)務(wù)。支撐這一觀點(diǎn)的事實(shí)是，柯達(dá)醫(yī)療集團(tuán)公司當(dāng)時剛剛成功擺脫連續(xù)兩年的季度虧損。但對柯達(dá)來說，它可能別無選擇，因?yàn)樗浅Ｐ枰F(xiàn)金。2011年，銳珂醫(yī)療的營業(yè)收入達(dá)到了24億美元。

CareStream Health

????Kodak decided to sell off its health group in 2007 with a price tag in the neighborhood of $2.5 billion. Now under the name CareStream Health, it is a subsidiary of one of Canada's largest corporations, Onex Corporation (ONEXF). CareStream has a foothold in radiography, medical and dental imaging, healthcare IT, and molecular imaging. The sale garnered criticism at the time, as the medical imaging technology was seen by some as a steadier business than consumer imaging. To its defense, Kodak's health group had just come off two straight years of quarterly losses. And Kodak may not have had a choice as it was already scrambling for liquidity. CareStream brought in $2.4 billion in revenues in 2011.